Factors improving the outcome of patients re-irradiated with intensity-modulated radiotherapy (IMRT) for relapse or new head and neck cancer developed in irradiated areas.
Fiche publication
Date publication
juin 2018
Journal
Chinese clinical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine, Dr BOREL Christian, Pr NOEL Georges, Dr BURGY Mickaël
Tous les auteurs :
Ohnleiter T, Antoni D, Lefebvre F, Truntzer P, Schultz P, Burgy M, Borel C, Noël G
Lien Pubmed
Résumé
Patients with secondary/recurrent squamous cell head and neck cancer have poor prognoses. Re-irradiation is a treatment option. However, best technique to re-irradiate is not known. This study aims to evaluate the outcome of patients treated with curative-intent intensity-modulated radiotherapy (IMRT) re-irradiation (re-RT) for head and neck (H&N) cancers.
Mots clés
Head and neck cancer (H&N cancer), intensity-modulated radiotherapy(IMRT), prognostic factors, re-irradiation (re-RT)
Référence
Chin Clin Oncol. 2018 Jun 27;: